Scientists test drug mix safety in healthy volunteers
NCT ID NCT07088913
Summary
This study tested how an experimental cancer drug called capivasertib might change the way the body processes a common cholesterol-lowering drug, rosuvastatin. Twenty healthy volunteers took both drugs separately and together so researchers could measure the levels in their blood. The goal was to understand potential drug interactions to ensure future patient safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Baltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.